

HY-P99705 · 1 mg
MedChemExpress · Cat: HY-P99705
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/lifastuzumab-vedotin.html
Description
Lifastuzumab vedotin RG-7599; DNIB0600A is an antibody-drug conjugate ADC that comprises a humanized IgG1 anti-NaPi2b monoclonal antibody MNIB2126A and a potent antimitotic agent, monomethyl auristatin E MMAE , which inhibits cell division by blocking the polymerization of tubulin. Lifastuzumab vedotin has the potential for non-small cell lung cancer NSCLC and platinum-resistant ovarian cancer PROC research.







